Want to know the latest news and articles posted on Telix Pharmaceuticals?
Then subscribe to their feed now! You can receive their updates by email, via mobile or on your personal news page on this website.
See what they recently published below.
Website title: Home - Telix Pharmaceuticals
Is this your feed? Claim it!
Melbourne (Australia) and Indianapolis, IN (United States) | May 5, 2026
Telix today announces the publication of a new independent analysis of Phase 3 ZIRCON trial data in European Urology
Melbourne (Australia) and Indianapolis, IN (United States) | May 1, 2026
Telix today announces that the marketing authorization application (MAA) filed in Europe for TLX101-Px (O-(2-[18F]fluoroethyl)-L-tyrosine, 18F-FET), its glioma (brain cancer) imaging candidate
Melbourne (Australia) and Indianapolis, IN (United States) | April 30, 2026
TLX597-Tx is a PSMA[1]-targeting small molecule radioligand thera...Melbourne (Australia) and Indianapolis, IN (United States) | April 28, 2026
Telix announces an educational webinar exploring the evolution of PSMA[1]-targeted radionucli...
Melbourne (Australia) | April 22, 2026
Telix today announces that safety and tolerability data from the ProstACT Global Phase 3 study (Part 1) will be presented as a late-breaking oral presentation at the 2026 American Society of Clinical Oncology (ASCO) Annual Meet...